Treatment strategies for relapsed and refractory aggressive non-Hodgkin's lymphoma
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment strategies for relapsed and refractory aggressive non-Hodgkin's lymphoma
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 10, Issue 6, Pages 983-995
Publisher
Informa Healthcare
Online
2009-04-13
DOI
10.1517/14656560902895715
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic Factors and Clinical Outcomes of High-Dose Chemotherapy followed by Autologous Stem Cell Transplantation in Patients with Peripheral T Cell Lymphoma, Unspecified: Complete Remission at Transplantation and the Prognostic Index of Peripheral T Cell Lymphoma Are the Major Factors Predictive of Outcome
- (2009) Deok-Hwan Yang et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Phase II Study of Risk-Adapted Therapy of Newly Diagnosed, Aggressive Non-Hodgkin Lymphoma Based on Midtreatment FDG-PET Scanning
- (2009) Yvette L. Kasamon et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Bendamustine
- (2009) Matt Kalaycio CANCER
- Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma
- (2008) J. Ruan et al. ANNALS OF ONCOLOGY
- Intensive chemotherapy (high-dose CHOP/ESHAP regimen) followed by autologous stem-cell transplantation in previously untreated patients with peripheral T-cell lymphoma
- (2008) S. Mercadal et al. ANNALS OF ONCOLOGY
- Bortezomib in patients with relapsed or refractory mantle cell lymphoma: updated time-to-event analyses of the multicenter phase 2 PINNACLE study
- (2008) A. Goy et al. ANNALS OF ONCOLOGY
- Long-Term Results Of Autologous Hematopoietic Cell Transplantation For Peripheral T Cell Lymphoma: The Stanford Experience
- (2008) Andy I. Chen et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Allogeneic Transplantation with Reduced-Intensity Conditioning for Hodgkin and non-Hodgkin Lymphoma: Importance of Histology for Outcome
- (2008) Philippe Armand et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group
- (2008) C. H. Geisler et al. BLOOD
- Allogeneic transplantation following nonmyeloablative conditioning for aggressive lymphoma
- (2008) D G Maloney BONE MARROW TRANSPLANTATION
- High-dose Ara-C and beam with autograft rescue in R-CHOP responsive mantle cell lymphoma patients
- (2008) Mars B. van ’t Veer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Cancer Statistics, 2008
- (2008) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Long‐term results of the treatment of patients with mantle cell lymphoma with cladribine (2‐CDA) alone (95‐80‐53) or 2‐CDA and rituximab (N0189) in the North Central Cancer Treatment Group
- (2008) David J. Inwards et al. CANCER
- Low-dose, single-agent temsirolimus for relapsed mantle cell lymphoma
- (2008) Stephen M. Ansell et al. CANCER
- Mantle cell lymphoma: advances in biology and therapy
- (2008) Mitchell R Smith CURRENT OPINION IN HEMATOLOGY
- Temsirolimus downregulates p21 without altering cyclin D1 expression and induces autophagy and synergizes with vorinostat in mantle cell lymphoma
- (2008) Victor Y. Yazbeck et al. EXPERIMENTAL HEMATOLOGY
- Salvage therapy for relapsed or refractory diffuse large B-cell lymphoma: impact of prior rituximab
- (2008) R. Sud et al. HAEMATOLOGICA
- R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: the influence of prior exposure to rituximab on outcome. A GEL/TAMO study
- (2008) A. Martin et al. HAEMATOLOGICA
- Hematopoietic Cell Transplantation for Non-Hodgkin's Lymphoma: Yesterday, Today, and Tomorrow
- (2008) Frederick R. Appelbaum JOURNAL OF CLINICAL ONCOLOGY
- Lenalidomide for the Treatment of B-Cell Malignancies
- (2008) Asher A. Chanan-Khan et al. JOURNAL OF CLINICAL ONCOLOGY
- Graft-Versus-Lymphoma Effect for Aggressive T-Cell Lymphomas in Adults: A Study by the Société Française de Greffe de Moëlle et de Thérapie Cellulaire
- (2008) Steven Le Gouill et al. JOURNAL OF CLINICAL ONCOLOGY
- Lenalidomide Monotherapy in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
- (2008) Peter H. Wiernik et al. JOURNAL OF CLINICAL ONCOLOGY
- International Peripheral T-Cell and Natural Killer/T-Cell Lymphoma Study: Pathology Findings and Clinical Outcomes
- (2008) JOURNAL OF CLINICAL ONCOLOGY
- Phase II Multicenter Study of Bendamustine Plus Rituximab in Patients With Relapsed Indolent B-Cell and Mantle Cell Non-Hodgkin's Lymphoma
- (2008) K. Sue Robinson et al. JOURNAL OF CLINICAL ONCOLOGY
- Improvement of Overall Survival in Advanced Stage Mantle Cell Lymphoma
- (2008) Annina Herrmann et al. JOURNAL OF CLINICAL ONCOLOGY
- Autologous Stem-Cell Transplantation As First-Line Therapy in Peripheral T-Cell Lymphomas: Results of a Prospective Multicenter Study
- (2008) Peter Reimer et al. JOURNAL OF CLINICAL ONCOLOGY
- Low-dose metronomic, multidrug therapy with the PEP-C oral combination chemotherapy regimen for mantle cell lymphoma
- (2008) Morton Coleman et al. LEUKEMIA & LYMPHOMA
- Salvage chemotherapy with rituximab DHAP for relapsed non-Hodgkin lymphoma: A phase II trial in the North Central Cancer Treatment Group
- (2008) Thomas E. Witzig et al. LEUKEMIA & LYMPHOMA
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started